Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...

For non-planar graphs, such solutions are computationally intractable," explained the researchers. The algorithm relies on the Kac-Ward formalism, a mathematical method that allows exact computation ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...

Colorectal cancer legal and administrative burden support (COLLABS): A pilot clinical trial. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does ...

If you’ve been making the same commute for a long time, you’ve probably settled on what seems like the best route. But “best” is a slippery concept. Perhaps one day there’s an accident or road closure ...

Abstract: This paper proposes a randomized algorithm for feasibility of uncertain LMIs. The algorithm is based on the solution of a sequence of semidefinite optimization problems involving a reduced ...

BreAK CRC, a first-in-human phase I/II trial of STC-1010, a new allogenic cancer vaccine for advanced or metastatic unresectable colorectal cancer. This is an ASCO Meeting Abstract from the 2024 ASCO ...

Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart ...

The prolific researcher found deep connections between randomness and computation and spent a career influencing cryptographers, complexity researchers and more. For more than 40 years, Avi Wigderson ...